Literature DB >> 9029034

Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression.

S Alkan1, D S Karcher, A Ortiz, S Khalil, M Akhtar, M A Ali.   

Abstract

Several recent studies have demonstrated Kaposi's sarcoma-associated herpes virus (KSHV), also known as putative human herpes virus-8 (HHV-8), DNA in various epidemiologic forms of Kaposi's sarcoma (KS), including AIDS-associated, classic, and endemic types. Risk of developing KS in non-HIV-infected immunosuppressed hosts, such as patients following solid organ transplantation, is also significantly higher compared to normal individuals. We have retrospectively evaluated 28 organ transplant patients with KS (23 cutaneous and five visceral) for the presence of KSHV genome by polymerase chain reaction (PCR) amplification of DNA isolated from formalin-fixed, paraffin-embedded archival tissue samples. 27/28 KS patients were positive for the presence of KSHV. In four KS patients, tissue samples with no histologic evidence of KS were also analysed for KSHV. No evidence of positivity in three samples was noted, but one patient had weak positive amplification products on DNA samples isolated from a gastric biopsy with chronic gastritis and lymph node with sinus histiocytosis. These data support the association of KSHV with KS developing in non-HIV-infected immunosuppressed patients, similar to other forms of KS, and suggest that KSHV may play a significant role in the development of all forms of KS.

Entities:  

Mesh:

Year:  1997        PMID: 9029034     DOI: 10.1046/j.1365-2141.1997.d01-2040.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Recent Advances in the Management of Infections in Liver Transplant Recipients.

Authors:  Nina Singh
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

2.  Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions.

Authors:  K E Foreman; S Alkan; A E Krueger; J R Panella; L J Swinnen; B J Nickoloff
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 3.  New and emerging infectious diseases.

Authors:  G L Mandell; G C Townsend
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

4.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.

Authors:  Jianjiang Ye; Duane Shedd; George Miller
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

Authors:  Moon Jung Song; Xudong Li; Helen J Brown; Ren Sun
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest.

Authors:  Yoshihiro Izumiya; Su-Fang Lin; Thomas J Ellison; Alon M Levy; Greg L Mayeur; Chie Izumiya; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  [Infections under immunosuppressive therapy following organ transplantation].

Authors:  L Renders; H Schöcklmann; U Kunzendorf
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

9.  KSHV downregulation of galectin-3 in Kaposi's sarcoma.

Authors:  Donald J Alcendor; Susan M Knobel; Prashant Desai; Wen Q Zhu; Hollie E Vigil; Gary S Hayward
Journal:  Glycobiology       Date:  2009-12-29       Impact factor: 4.313

10.  Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression.

Authors:  Yoshihiro Izumiya; Su-Fang Lin; Thomas Ellison; Ling-Yu Chen; Chie Izumiya; Paul Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.